Insulet share price logo

Insulet

NASDAQ: PODD

Mid Cap

$133.17

-4.06

(-2.96%)

as on

Insulet Stock Performance

as on November 21, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $132.47
    $140.31
    downward going graph

    0.53%

    Downside

    5.36%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $126.40
    $342.13
    downward going graph

    5.08%

    Downside

    156.91%

    Upside

    downward going graph

Insulet share price movements today

Previous Close
$137.23
Open
$134.97
Volume
875.2K
Market Cap
$9.5B
Day's Low - High
$132.47 - $140.31
52 Week Low - High
$126.40 - $342.13

Insulet Historical Returns

1 Month Return
-6.15 %
3 Month Return
-10.12 %
1 Year Return
-59.79 %
3 Year Return
-26.56 %
5 Year Return
-55.76 %

Insulet Stock Fundamentals & Key Indicators

Check Insulet market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.5B

EPS (TTM)

6.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.64%

PE Ratio (TTM)

22.31

Industry PE ratio

27.49

PEG Ratio

0.29

EBITDA

686.3M

Revenue (TTM)

3.2B

Profit Margin

71.88%

Return On Equity TTM

29.48%

Insulet vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Insulet with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$9.5B-55.76%22.3171.88%0.00%
StrongBuy$61.6B-12.97%58.6978.13%0.00%
Buy$128.7B-14.74%24.6666.69%2.84%
StrongBuy$119.2B17.56%33.1365.52%1.12%
StrongBuy$179.9B-18.80%38.5157.04%2.43%

Stock Returns calculator for Insulet Stock including INR - Dollar returns

The Insulet stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Insulet investment value today

Current value as on today

₹41,801

Returns

-₹58,199

(-58.2%)

Returns from Insulet Stock

-₹59,788 (-59.79%)

Dollar Impact

₹1,589 (+1.59%)

Analyst Recommendation on Insulet Stock

Based on 9 analysts

HOLD

22.22%

Buy

77.78%

Hold

0.00%

Sell

Based on 9 analysts, 77.77777777777779% of analysts recommend a 'HOLD' rating for Insulet. Average target price of $177.91

Insulet Share Price Target

Get share price movements and forecasts by analysts on Insulet.

What analysts predicted

25.15%UPSIDE

Target Price

$177.91

Current Price

$133.17

Analyzed by

9 Analysts

High

$190

Target

$177.91

Low

$158

Insulet target price $177.91, a slight upside of 25.15% compared to current price of $133.17. According to 9 analysts rating.

Indian Investors' Interest in Insulet Stock

Search interest for Insulet Stock has increased by 41% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:41% versus previous 30 day period

Insulet Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
488
543
597
569
649
706
783
761
801
842
Gross Profit
330
377
430
409
452
510
568
529
562
632
Operating Income
54
88
109
88
121
117
146
122
129
189
EBITDA
81
116
141
79
70
160
184
153
158
189
Interest Expense
11
12
8
9
19
15
19
14
13
12
Depreciation
19
21
21
21
22
22
24
26
26
-
Income Before Tax
51
82
111
48
28
122
140
113
118
177
Income Tax Expense
-137
5
10
12
5
35
38
21
23
36
Net Income
188
77
100
35
22
87
101
91
95
141
Net Profit Margin
67.74%
69.33%
72.12%
71.88%
69.67%
72.22%
72.54%
69.46%
70.18%
75.07%

Insulet Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
463
563
738
904
1,098
1,305
1,697
2,071
2,708
Gross Profit
277
370
480
582
752
805
1,159
1,445
1,939
Operating Income
-7
27
50
51
126
37
220
308
473
EBITDA
6
47
74
110
139
109
323
423
509
Interest Expense
19
22
34
48
61
36
36
42
79
Depreciation
13
15
27
55
57
63
72
80
90
Income Before Tax
-26
5
14
9
20
9
214
300
339
Income Tax Expense
0
1
2
2
3
5
8
-118
92
Net Income
-26
3
11
6
16
4
206
418
247
Net Profit Margin
59.76%
65.65%
65.06%
64.39%
68.45%
61.72%
68.35%
69.79%
71.63%

Insulet Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
188
77
100
35
22
87
101
91
95
141
Operating Cash Flow
86
98
147
63
196
125
183
113
88
123
Investing Cash Flow
-24
-29
-68
-15
-23
-31
-152
-27
-37
-66
Financing Cash Flow
8
7
-20
277
-343
-456
-72
-319
4
-6
Change in Cash
69
81
50
329
-161
-364
-41
-235
54
49

Insulet Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
3
11
6
16
4
206
418
247
Operating Cash Flow
41
35
98
84
-68
119
145
430
569
Investing Cash Flow
-210
-184
-73
14
-82
-191
-119
-146
-222
Financing Cash Flow
304
-8
73
605
40
-40
-13
-28
-595
Change in Cash
135
-158
99
708
-115
-116
14
249
-237

Global Institutional Holdings in Insulet

Check out the Institutions with significant holdings in Insulet.

Funds
Holdings
Shares Held
Vanguard
9.64%
6685562
VANGUARD INDEX FUNDS
9.37%
6497602
BlackRock, Inc.
8.48%
5879234
Amundi
6.13%
4252547
iShares
5.80%
4024194

Insulet News & Key Events

  • img

    Today's Timeline - 20 November

    Fri, 08:15 PM

    -

    Baird downgraded Insulet to Neutral from Outperform, lowering price target to $158 due to brand loyalty concerns.

    Sat, 03:10 AM

    -

    Insulet reappointed Michael Minogue to its board, with analysts rating PODD stock as Hold with a $158 price target.

    Sat, 07:44 AM

    -

    Insulet's cash flow projections suggest long-term value despite a 59.8% share price decline over the past year.

Insights on Insulet

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 91.10M → 141.09M (in $), with an average increase of 18.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 761.70M → 841.99M (in $), with an average increase of 4.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 51.9% return, outperforming this stock by 80.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 19.6% return, outperforming this stock by 79.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, PODD stock has moved down by -59.8%

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
OrganisationInsulet
Headquarters100 Nagog Park, Acton, MA, 01720, US
IndustryMedical - Devices
CEOAshley McEvoy

Key Management of Insulet

Name

Title

Ms. Flavia H. Pease

Executive VP & CFO

Mr. Eric Benjamin

Executive VP & COO

Mr. Prem Singh

Senior Vice President of Global Operations

Ms. Clare Trachtman

Vice President of Investor Relations

Mr. Chuck Medovich

Senior VP and Chief Quality, Regulatory & Compliance Officer

Ms. Angela Geryak Wiczek

Senior Director of Corporate Communications

Ms. Ashley A. McEvoy

CEO, President & Director

Mr. John Wodick Kapples J.D.

Senior VP & General Counsel

Mr. Amit Guliani

Senior VP & CTO

Mr. Philip Hildale

Senior Vice President of Sales & Customer Care

FAQs

What is Insulet share price today?

Insulet share price today is $133.17 as on at the close of the market. Insulet share today touched a day high of $140.31 and a low of $132.47.

What is the 52 week high and 52 week low for Insulet share?

Insulet share touched a 52 week high of $342.13 on and a 52 week low of $126.40 on . Insulet stock price today i.e. is closed at $133.17,which is 61.08% down from its 52 week high and 5.36% up from its 52 week low.

What is Insulet's market capitalisation today?

Insulet market capitalisation is $0.01T as on .

How to invest in Insulet Stock (PODD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Insulet on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Insulet Stock (PODD) from India?

Indian investors can start investing in Insulet (PODD) shares with as little as ₹92.66999816894531 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Insulet stock (as per the Rupee-Dollar exchange rate as on ). Based on Insulet share’s latest price of $133.17 as on November 21, 2026 at 8:46 am IST, you will get 0.0751 shares of Insulet. Learn more about fractional shares .

What are the returns that Insulet has given to Indian investors in the last 5 years?

Insulet stock has given -55.76% share price returns and 25.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?